235 related articles for article (PubMed ID: 6733002)
1. Plasma concentrations of unbound phenytoin in the management of epilepsy.
Kilpatrick CJ; Wanwimolruk S; Wing LM
Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
[TBL] [Abstract][Full Text] [Related]
2. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
Barth N; Alván G; Borgå O; Sjöqvist F
Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
[TBL] [Abstract][Full Text] [Related]
3. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
Johnson GJ; Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
[TBL] [Abstract][Full Text] [Related]
4. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
Knott C; Hamshaw-Thomas A; Reynolds F
Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
[TBL] [Abstract][Full Text] [Related]
5. Plasma protein binding of phenytoin in 100 epileptic patients.
Peterson GM; McLean S; Aldous S; Von Witt RJ; Millingen KS
Br J Clin Pharmacol; 1982 Aug; 14(2):298-300. PubMed ID: 7104186
[TBL] [Abstract][Full Text] [Related]
6. Effect of valproate on free plasma phenytoin concentrations.
Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
[TBL] [Abstract][Full Text] [Related]
7. Variability of phenytoin protein binding in epileptic patients.
DeMonaco HJ; Lawless LM
Arch Neurol; 1983 Aug; 40(8):481-3. PubMed ID: 6347141
[TBL] [Abstract][Full Text] [Related]
8. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
Kerrick JM; Wolff DL; Graves NM
Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
[TBL] [Abstract][Full Text] [Related]
9. Clinical response in epilepsy in relation to total and free serum levels of phenytoin.
Peterson GM; Khoo BH; von Witt RJ
Ther Drug Monit; 1991 Sep; 13(5):415-9. PubMed ID: 1957333
[TBL] [Abstract][Full Text] [Related]
10. Monitoring phenytoin in salivary and plasma ultrafiltrates of pediatric patients.
Bachmann K; Forney RB; Voeller K
Ther Drug Monit; 1983; 5(3):325-9. PubMed ID: 6636260
[TBL] [Abstract][Full Text] [Related]
11. Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Eur J Pharm Biopharm; 1999 May; 47(3):295-8. PubMed ID: 10382115
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an ultrafiltration-fluorescence polarization immunoassay for monitoring unbound phenytoin.
Argyle JC; Kinniburgh DW; Costa R; Jennison T
Ther Drug Monit; 1984; 6(1):117-20. PubMed ID: 6710555
[TBL] [Abstract][Full Text] [Related]
13. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
Oellerich M; Müller-Vahl H
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
[TBL] [Abstract][Full Text] [Related]
14. Should we routinely measure free plasma phenytoin concentration?
Rimmer EM; Buss DC; Routledge PA; Richens A
Br J Clin Pharmacol; 1984 Jan; 17(1):99-102. PubMed ID: 6419764
[TBL] [Abstract][Full Text] [Related]
15. Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication.
May T; Rambeck B
Ther Drug Monit; 1990 Mar; 12(2):124-8. PubMed ID: 2107607
[TBL] [Abstract][Full Text] [Related]
16. Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy.
Kodama H; Kodama Y; Itokazu N; Shinozawa S; Kanemaru R; Sugimoto T
J Clin Pharm Ther; 2001 Jun; 26(3):175-9. PubMed ID: 11422600
[TBL] [Abstract][Full Text] [Related]
17. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
[TBL] [Abstract][Full Text] [Related]
18. The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in children.
ter Heine R; van Maarseveen EM; van der Westerlaken MM; Braun KP; Koudijs SM; Berg MJ; Malingré MM
J Child Neurol; 2014 Jun; 29(6):803-10. PubMed ID: 23670246
[TBL] [Abstract][Full Text] [Related]
19. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction.
Montgomery MC; Chou JW; McPharlin TO; Baird GS; Anderson GD
Pharmacotherapy; 2019 Jul; 39(7):756-766. PubMed ID: 31067355
[TBL] [Abstract][Full Text] [Related]
20. A graphical nomogram method for predicting toxic concentrations of unbound phenytoin.
Pospisil J; Pelclová D
Int J Clin Pharmacol Ther; 1994 Mar; 32(3):122-5. PubMed ID: 8205372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
